izpis_h1_title_alt

Pathological and therapeutic significance of tumor-derived extracellular vesicles in cancer cell migration and metastasis
ID Liguori, Giovanna L. (Author), ID Kralj-Iglič, Veronika (Author)

.pdfPDF - Presentation file, Download (1,65 MB)
MD5: 4282A9CA9FD2CAD82F20F2F4C942677F
URLURL - Source URL, Visit https://www.mdpi.com/2072-6694/15/18/4425 This link opens in a new window

Abstract
The infiltration of primary tumors and metastasis formation at distant sites strongly impact the prognosis and the quality of life of cancer patients. Current therapies including surgery, radiotherapy, and chemotherapy are limited in targeting the complex cell migration mechanisms responsible for cancer cell invasiveness and metastasis. A better understanding of these mechanisms and the development of new therapies are urgently needed. Extracellular vesicles (EVs) are lipid enveloped particles involved in inter-tissue and inter-cell communication. This review article focuses on the impact of EVs released by tumor cells, specifically on cancer cell migration and metastasis. We first introduce cell migration processes and EV subtypes, and we give an overview of how tumor derived EVs (TDEVs) may impact cancer cell migration. Then, we discuss ongoing EV-based cancer therapeutic approaches, including the inhibition of general EV-related mechanisms as well as the use of EVs for anti-cancer drug delivery, focusing on the harnessing of TDEVs. We propose a protein-EV shuttle as a route alternative to secretion or cell membrane binding, influencing downstream signaling and the final effect on target cells, with strong implications in tumorigenesis. Finally, we highlight the pitfalls and limitations of therapeutic EV exploitation that must be overcome to realize the promise of EVs for cancer therapy.

Language:English
Keywords:extracellular vesicles, tumor-derived extracellular vesicles, cancer cell migration, epithelial-mesenchymal transition, tumor metastasis, cancer therapy, alternative signaling routes, drug delivery, extracellular vesicle exploitation, quality control
Work type:Article
Typology:1.02 - Review Article
Organization:ZF - Faculty of Health Sciences
Publication status:Published
Publication version:Version of Record
Publication date:05.09.2023
Year:2023
Number of pages:23 str.
Numbering:Vol. 15, iss.18, art. 4425
PID:20.500.12556/RUL-149870 This link opens in a new window
UDC:577:616-006
ISSN on article:2072-6694
DOI:10.3390/cancers15184425 This link opens in a new window
COBISS.SI-ID:163943939 This link opens in a new window
Publication date in RUL:11.09.2023
Views:1229
Downloads:53
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancers
Shortened title:Cancers
Publisher:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:05.09.2023

Projects

Funder:EC - European Commission
Funding programme:European Commission
Project number:801338
Name:Extracellular vesicles from a natural source for tailor-made nanomaterials
Acronym:VES4US

Funder:ARRS - Slovenian Research Agency
Project number:P3-0388-2022
Name:Mehanizmi varovanja zdravja

Funder:ARRS - Slovenian Research Agency
Project number:J3-3066-2021
Name:Optimizacija s trombociti in zunajceličnimi vezikli bogate avtologne krvne plazme za zdravljenje pooperativnih ran v otorinolaringologiji

Funder:ARRS - Slovenian Research Agency
Project number:L3-2621-2020
Name:Mehanizmi omajanja endoproteze kolka

Funder:ARRS - Slovenian Research Agency
Project number:J2-4447-2022
Name:Vpliv mehanike in topologije membrane na celično ujetje bakterij, virionov in anorganskih delcev

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back